These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Author: Shen HH, Hou J, Zhao M, Xu J, Bai BK, Zhao J, Hu Y, Mao PY, Li BA, Mao YL.
    Journal: Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841.
    Abstract:
    OBJECTIVE: To understand the hemagglutination inhibition antibody level in patients with influenza A H1N1. METHODS: Sera from 28 patients with influenza A H1N1 at different time points after illness onset were collected and measured by hemagglutination inhibition assay. RESULTS: The serum hemagglutination inhibition antibody titers at 1, 5, 15, 22, 37, 49 and 58 days after illness onset were 5.36, 9.39, 39.02, 57.99, 137.92, 55.19 and 57.99 respectively. The top geometric mean titer of hemagglutination inhibition antibody was 148.55. The antibody seroconversion rate and seroprotection rate were occurred in 96.4% (27/28) of patients. CONCLUSION: The patients with influenza A H1N1 have effective immune response.
    [Abstract] [Full Text] [Related] [New Search]